Fingerprint
Dive into the research topics of 'Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs
Janice Kim, Abhilasha Nair, Patricia Keegan, Julia A. Beaver, Paul G. Kluetz, Richard Pazdur, Meredith Chuk, Gideon M. Blumenthal
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations